e-learning
resources
Virtual 2020
Pre-Congress Content
Pathophysiology and treatment of obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of hyaluronan metabolism in obstructive sleep apnoea
M. Meszaros (Budapest, Hungary), Z. Lazar (Budapest, Hungary), A. Tarnoki (Budapest, Hungary), D. Tarnoki (Budapest, Hungary), A. Kis (Budapest, Hungary), L. Kunos (Budapest, Hungary), A. Bikov (Manchester, United Kingdom)
Source:
Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Session:
Pathophysiology and treatment of obstructive sleep apnoea
Session type:
E-poster session
Number:
1334
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Meszaros (Budapest, Hungary), Z. Lazar (Budapest, Hungary), A. Tarnoki (Budapest, Hungary), D. Tarnoki (Budapest, Hungary), A. Kis (Budapest, Hungary), L. Kunos (Budapest, Hungary), A. Bikov (Manchester, United Kingdom). The role of hyaluronan metabolism in obstructive sleep apnoea. 1334
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The role of angiogenesis in obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005
The role of inflammatory biomarkers in obstructive sleep apnea syndrome
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018
Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
The vascular micromilieu in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 780-782
Year: 2005
Cortisol metabolism in obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002
Roles of periostin in patients with severe obstructive sleep apnea
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017
Local airway inflammation in obstructive sleep apnoea: the role of leptin
Source: Eur Respir J 2006; 28: Suppl. 50, 645s
Year: 2006
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
The puzzle of metabolic effects of obstructive sleep apnoea in children
Source: Eur Respir J 2016; 47: 1050-1053
Year: 2016
The metabolic consequences of obstructive sleep apnoea in children
Source: Breathe 2009; 6: 111-114
Year: 2009
Leptin in obstructive sleep apnea
Source: Eur Respir J 2001; 18: Suppl. 33, 333s
Year: 2001
Erythrocyte production in obstructive sleep apnea
Source: Eur Respir J 2004; 24: Suppl. 48, 692s
Year: 2004
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
The velumount device for obstructive sleep apnoea
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
The impact of obstructive sleep apnoea on the aorta
Source: Eur Respir J 2015; 46: 532-544
Year: 2015
Hepcidin: the new marker for determining nocturnal hypoxia in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Catecholamine secretion in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005
Can leptin be used to treat obstructive sleep apnoea?
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
Endothelial function in obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Does obstructive sleep apnoea predispose to reduced renal function?
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept